{"id":"https://openalex.org/W2602013400","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","title":"The occurrence of grade 4 adverse events and survival outcomes in patients with nonsquamous non-small cell lung cancer receiving bevacizumab with chemotherapy in the phase III PointBreak and AVAiL studies.","display_name":"The occurrence of grade 4 adverse events and survival outcomes in patients with nonsquamous non-small cell lung cancer receiving bevacizumab with chemotherapy in the phase III PointBreak and AVAiL studies.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2602013400","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","mag":"2602013400"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.e19022","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082389042","display_name":"Liza Cosca Villaruz","orcid":"https://orcid.org/0000-0001-7456-523X","observed_orcids":["https://orcid.org/0000-0001-7456-523X"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Cosca Villaruz","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033948459","display_name":"Jyoti D. Patel","orcid":"https://orcid.org/0000-0002-7550-2094","observed_orcids":["https://orcid.org/0000-0002-7550-2094"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jyoti D. Patel","raw_affiliation_strings":["Feinberg School of Medicine, Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feinberg School of Medicine, Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Larry Leon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Leon","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089764941","display_name":"Sebastien J. Hazard","orcid":"https://orcid.org/0000-0001-5740-1188","observed_orcids":["https://orcid.org/0000-0001-5740-1188"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastien Hazard","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046728958","display_name":"Martin Reck","orcid":"https://orcid.org/0000-0002-5348-4462","observed_orcids":["https://orcid.org/0000-0002-5348-4462"]},"institutions":[{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Reck","raw_affiliation_strings":["Hospital Grosshansdorf, Department of Thoracic Oncology, Grosshansdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Grosshansdorf, Department of Thoracic Oncology, Grosshansdorf, Germany","institution_ids":["https://openalex.org/I4210140903"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"e19022","last_page":"e19022"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.22849999368190765,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9129999876022339},{"id":"https://openalex.org/keywords/non-squamous-non-small-cell-lung-cancer","display_name":"non-squamous non-small cell lung cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9120000004768372},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7260000109672546},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7310000061988831},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9133740067481995},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7319602370262146},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7190119028091431},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6856313347816467},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.6208339929580688},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6041321158409119},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5951221585273743},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5903645753860474},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5273761749267578},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5265614986419678},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48473355174064636},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4841485619544983},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.45027416944503784},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3857596516609192},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.363962322473526},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.27792102098464966},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2773085832595825},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.11834955215454102}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.e19022","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e19022","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2154210596","https://openalex.org/W2115330744","https://openalex.org/W1517538518","https://openalex.org/W2287085364","https://openalex.org/W2111815439","https://openalex.org/W2144660856","https://openalex.org/W2406780605","https://openalex.org/W2148367564","https://openalex.org/W2594893522","https://openalex.org/W2134693386"],"abstract_inverted_index":{"e19022":[0],"Background:":[1],"Progression-free":[2],"survival":[3,26,81],"(PFS)":[4],"is":[5,53],"a":[6,18,43,54,59,191,217],"key":[7],"trial":[8,287],"end":[9,56],"point":[10,57],"for":[11,112,137,172,186],"clinical":[12],"practice,":[13],"as":[14,29],"it":[15],"relates":[16],"to":[17,34,63,98,165],"change":[19],"of":[20,37,42,61,74,190,197,208,213,234,242],"treatment":[21,32,198],"line.":[22],"Grade":[23],"4":[24],"progression-free":[25],"(G4PFS;":[27],"defined":[28],"time":[30],"from":[31,50],"start":[33],"the":[35,72,223,229,239,259],"earlier":[36],"progressive":[38],"disease":[39],"[PD],":[40],"onset":[41],"G4":[44,75,192,218,226,250,272],"adverse":[45],"event":[46],"[AE],":[47],"or":[48,109,120,127,143,146,281],"death":[49],"any":[51],"cause)":[52],"composite":[55],"incorporating":[58],"measure":[60],"tolerability":[62],"PFS.":[64,271],"This":[65],"post":[66],"hoc":[67],"analysis":[68],"evaluates":[69],"G4PFS":[70,265],"and":[71,79,90,106,135,140,159,168,175,178,211,237,247,261,290],"effect":[73],"AEs":[76,152],"on":[77],"PFS":[78,177,280],"overall":[80],"(OS)":[82],"in":[83,87,94,131,183,228,238,283],"patients":[84],"(pts)":[85],"enrolled":[86],"PointBreak":[88],"(PB)":[89],"AVAiL.":[91],"Methods:":[92],"Pts":[93,130],"PB":[95,214,235,260],"were":[96,153,163,180],"randomized":[97],"bevacizumab":[99],"(BEV)":[100],"15":[101,147],"mg/kg":[102],"q3w":[103,124,149],"with":[104,188],"carboplatin":[105],"paclitaxel":[107],"(CP)":[108],"pemetrexed":[110],"(CPem)":[111],"\u22644":[113],"cycles.":[114],"Eligible":[115],"pts":[116,187,210,215],"received":[117,133],"either":[118,141,284],"BEV":[119,121,144,232,240],"+":[122,231],"Pem":[123],"until":[125,150],"PD":[126],"unacceptable":[128],"toxicity.":[129],"AVAiL":[132,209,243,262],"cisplatin":[134],"gemcitabine":[136],"\u22646":[138],"cycles":[139],"placebo":[142],"(7.5":[145],"mg/kg)":[148],"PD.":[151],"graded":[154],"via":[155],"NCI-CTCAE":[156],"v3.0.":[157],"Kaplan-Meier":[158],"Cox":[160],"model":[161],"methods":[162],"used":[164],"estimate":[166],"medians":[167],"hazard":[169],"ratios":[170],"(HRs)":[171],"PFS,":[173,245],"G4PFS,":[174,246],"OS.":[176],"OS":[179,282],"also":[181],"compared":[182],"each":[184],"arm":[185,233],"occurrence":[189,252],"AE":[193,227,251,273],"before":[194],"week":[195],"12":[196],"vs":[199],"those":[200,204],"without.":[201],"Results:":[202],"Of":[203],"receiving":[205],"BEV,":[206],"~30%":[207],"38%":[212],"had":[216],"AE.":[219],"Uncomplicated":[220],"neutropenia":[221],"was":[222,266],"most":[224],"common":[225],"CP":[230],"(26%)":[236],"arms":[241],"(11%).":[244],"outcomes":[248],"by":[249],"are":[253],"shown":[254],"(Table).":[255],"Conclusions:":[256],"In":[257],"both":[258],"trials,":[263],"median":[264,270],"numerically":[267],"shorter":[268],"than":[269],"occurrence,":[274],"however,":[275],"did":[276],"not":[277],"affect":[278],"subsequent":[279],"trial.":[285],"Clinical":[286],"information:":[288],"NCT00762034":[289],"NCT00806923.":[291],"[Table:":[292],"see":[293],"text]":[294]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}